Skip to main content

Table 3 Multivariate analysis of prognostic factors for overall survival

From: Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study

Variables

HR (95% CI)

P value

Tumor size

1.090 (0.991, 1.199)

0.075

α-Fetoprotein level

  

 > 400 ng/mL

1

 

 ≤ 400 ng/ml

1.446 (0.851, 2.456)

0.173

Child–Pugh score

  

A

1

 

B

0.587 (0.340, 1.013)

0.056

BCLC stage

  

A

  

B

0.544 (0.306, 0.968)

0.038

Treatment method

  

Early-RFA

1

 

Late-RFA

0.659 (0.415, 1.049)

0.079

  1. HR: Hazard ratio; CI: Confidence interval; BCLC: Barcelona Clinic Liver Cancer; RFA: Radiofrequency ablation
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us